The Division of Hematology/Oncology diagnoses, evaluates and treats patients with malignant diseases (cancers) and hematologic disorders (involving the blood and blood-forming organs), including:
- Bleeding disorder (including low platelet levels, or easy bruising or bleeding)
- Blood-related disorder
- Blood and marrow disorder (including leukemia)
- Cancer or malignant disease (rare and common)
- Myeloproliferative disorder (excessive production of blood cells and platelets)
- Myelodysplastic syndrome (ineffective generation of blood cells)
Mayo physicians and staff work closely with surgeons, radiation oncologists, and other specialists to:
- Help patients understand their diagnosis
- Develop individualized treatment plans (ranging from supportive care to intensive chemotherapy and aggressive treatments)
- Coordinate all aspects of treatment
- Provide effective surgical, chemotherapy and immunotherapy treatment
To provide the most effective care, Mayo's hematologists and oncologists work together in disease-oriented treatment groups, combining the expertise and results of more than 100 active treatment programs at all three Mayo Clinic campuses that study and treat cancers. This allows Mayo patients to benefit from the latest advances in prevention, detection, treatment and supportive care.
The Division of Hematology/Oncology also supports several specialty treatment programs.
The Breast Clinic evaluates patients whose breast examinations or mammograms have indicated abnormal findings, and treats patients who have recently been diagnosed with breast cancer.
Blood and Marrow Transplant Program
The Blood and Marrow Transplant Program is known for its safe and effective approach to transplantation. The program helps patients with certain solid tumors and many hematologic disorders, including:
Myeloma and Macroglobulinemia Treatment Group
The Myeloma and Macroglobulinemia Treatment Group provides diagnosis, prognosis and treatment strategies for patients with blood and marrow problems.
Chemotherapy and Infusion Centers
The treatments provided through the division's outpatient chemotherapy and infusion centers help prolong the survival of cancer patients, allowing many patients to maintain a good quality of life. Many different therapy programs are available and are often successful in inducing remissions.